Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Peptide Process CMCPeptide Process CMC
Not Confirmed
Not Confirmed
28-30 August, 2025
Not Confirmed
Not Confirmed
01-03 September, 2025
Process DevelopmentProcess Development
Not Confirmed
Not Confirmed
01 September, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Peptide Process CMCPeptide Process CMC
Industry Trade Show
Not Confirmed
28-30 August, 2025
Industry Trade Show
Not Confirmed
01-03 September, 2025
Process DevelopmentProcess Development
Industry Trade Show
Not Confirmed
01 September, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/50-years-of-innovation-mikart-s-legacy-and-what-s-next-in-cdmo-excellence
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/fda-approvals-drop-24-in-h1-2025-gsk-s-uti-med-vertex-s-non-opioid-painkiller-lead-pack-of-first-in-class-meds
21 Feb 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/02/21/3030444/21662/en/Tempus-and-Stemline-Therapeutics-Inc-A-Subsidiary-of-the-Menarini-Group-Announce-Collaboration-to-Implement-Tempus-Next-an-AI-Enabled-Care-Pathway-Intelligence-Platform-to-Support-.html
11 Dec 2024
// BUSINESSWIRE
04 Jan 2024
// Gabrielle Masson FIERCE BIOTECH
https://www.fiercebiotech.com/biotech/menarini-groups-stemline-inks-500m-biobucks-deal-insilicos-breast-cancer-candidate
09 Oct 2023
// EMA
https://www.ema.europa.eu/en/documents/overview/orserdu-epar-medicine-overview_en.pdf
21 Sep 2023
// BUSINESSWIRE
https://www.businesswire.com/news/home/20230920907427/en/European-Commission-Approves-Menarini-Group%E2%80%99s-ORSERDU%C2%AE-Elacestrant-for-the-Treatment-of-Patients-with-ER-HER2--Locally-Advanced-or-Metastatic-Breast-Cancer-with-an-Activating-ESR1-Mutation
30 Aug 2023
// BUSINESSWIRE
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE